🇺🇸 Nabilone Capsules in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 1
Most-reported reactions
- Cellulitis — 1 report (100%)
Frequently asked questions
Is Nabilone Capsules approved in United States?
Nabilone Capsules does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Nabilone Capsules in United States?
Eldon Loh, MD is the originator. The local marketing authorisation holder may differ — check the official source linked above.